Physician · AI Scientist · Founder of Silicura AI
I build human-governed agentic AI systems for drug development—connecting scientific evidence, multimodal biomedical data, model outputs, uncertainty, and expert judgment across therapeutic research.
My work spans computational therapeutics, biometrics, clinical development, advanced analytics, and medical affairs. I combine hands-on model development, GPU computing, data engineering, and agentic orchestration with scientific strategy and governance.
Silicura AI is developing a research-stage, GPU-accelerated computational foundation designed to help scientific teams structure complex biological questions, compare plausible therapeutic directions, and preserve traceability from evidence to decision.
Current platform directions include:
- Drug Builder — a confidential agentic workspace under active development
- Digital Wet Lab AI — multimodal biological reasoning and computational experimentation
- Clinical Development AI — human-governed protocol intelligence, trial exploration, and biometrics
- Medical Affairs AI — evidence intelligence and traceable scientific workflows
Silicura AI is a member of NVIDIA Inception and has filed three U.S. provisional patent applications.
- Agentic Drug Development AI
- Agentic Digital Wet Lab AI
- Agentic Clinical Development AI
- Agentic Medical Affairs AI
Public materials are intentionally bounded. Patent-sensitive methods, system architecture, configurations, prompts, workflows, and program data remain confidential.